TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01973608

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study is terminated prematurely as the sponsor decided to discontinue program of NHS-IL2 \[MSB0010445\]”

The sponsor’s own words in the registry.

Life of this trial

20132014201520162017Registered2013-10-25Started2014-01Primary completion2015-04Stopped2015-06Results posted2016-10-31

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
EMD Serono
Sponsor type
Industry
Conditions
Melanoma
Interventions
MSB0010445 (0.3 milligram per kilogram [mg/kg]); MSB0010445 (1.0 mg/kg); MSB0010445 (1.8 mg/kg); MSB0010445 (2.4 mg/kg); Stereotactic Body Radiation Therapy (SBRT)
Participants
12
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.